1-5 of 5
Xinliang Mao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A225: Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through structural optimization.

Free
Kunkun Han, Xin Xu, Guodong Chen, Yuanying Zeng, Jingyu Zhu, Xiaolin Du, Zubin Zhang, Biyin Cao, Zhaopeng Liu, Xinliang Mao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A225.
https://doi.org/10.1158/1535-7163.TARG-13-A225
Published: 01 November 2013
View article titled, Abstract A225: Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through structural optimization.
Journal Articles

Abstract A230: An anti-leishmanial thiadiazine agent induces multiple myeloma cell apoptosis by suppressing the nuclear factor kappaB signaling pathway.

Free
Guodong Chen, Kunkun Han, Xin Xu, Xiaolin Du, Zubin Zhang, Juan Tang, Min Shi, Man Wang, Jie Li, Biyin Cao, Xinliang Mao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A230.
https://doi.org/10.1158/1535-7163.TARG-13-A230
Published: 01 November 2013
View article titled, Abstract A230: An anti-leishmanial thiadiazine agent induces multiple myeloma cell apoptosis by suppressing the nuclear factor kappaB signaling pathway.
Journal Articles

Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands

Free
Tabitha E. Wood, Shadi Dalili, Craig D. Simpson, Mahadeo A. Sukhai, Rose Hurren, Kika Anyiwe, Xinliang Mao, Fernando Suarez Saiz, Marcela Gronda, Yanina Eberhard, Neil MacLean, Troy Ketela, John C. Reed, Jason Moffat, Mark D. Minden, Robert A. Batey, Aaron D. Schimmer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (1): 246–256.
https://doi.org/10.1158/1535-7163.MCT-09-0495
Published: 12 January 2010
View article titled, Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
Open the PDF for Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands in another window
Includes: Supplementary data
Journal Articles

A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death

Free
Tabitha E. Wood, Shadi Dalili, Craig D. Simpson, Rose Hurren, Xinliang Mao, Fernando Suarez Saiz, Marcela Gronda, Yanina Eberhard, Mark D. Minden, Philip J. Bilan, Amira Klip, Robert A. Batey, Aaron D. Schimmer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (11): 3546–3555.
https://doi.org/10.1158/1535-7163.MCT-08-0569
Published: 11 November 2008
View article titled, A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Open the PDF for A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death in another window
Journal Articles

Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent

Free
Kenneth W. Yip, Emma Ito, Xinliang Mao, P.Y. Billie Au, David W. Hedley, Joseph D. Mocanu, Carlo Bastianutto, Aaron Schimmer, Fei-Fei Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (9): 2234–2240.
https://doi.org/10.1158/1535-7163.MCT-06-0134
Published: 19 September 2006
View article titled, Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent
Open the PDF for Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent in another window